期刊文献+

HLA-DRB1^*1501和DQB1^*0602与新疆哈萨克族HPV感染及食管癌发生的相关性研究 被引量:2

Study of the Relationship Between HLA DRB1^*1501, DQB1^*0602 and Xinjiang Kazakh National Minority HPV Infection and Esophageal Carcinoma
下载PDF
导出
摘要 目的:从基因水平探讨新疆哈萨克族食管鳞癌的HPV16E6感染及食管鳞癌发生与HLA—DRB1,DQB1等位基因的遗传易感性,为寻找哈萨克族食管鳞癌的易感基因提供参考。方法:采用聚合酶链反应(PCR)技术检测200例哈萨克族食管鳞癌和150例哈族萨克正常人群HPV16E6基因的表达情况,运用序列特异性引物聚合酶链反应技术(PCR—SSP),检测新疆哈萨克族食管鳞癌患者200例,哈萨克族正常人群食管膜膜150例的HLA—DRB1^*1501和HLA—DQB1^*0602的分布。结果:新疆哈萨克族食管鳞癌患者HPV16E6感染率为41%,明显高于哈萨克族正常人群感染率的14%(P〈0.001,OR=3.94);HPV16E6感染与哈萨克族正常人群HLA—DRB1^*1501,HLA—DQB1^*0602的无相关性(P〉0.05);新疆哈萨克族食管鳞癌患者HLA—DRB1^*1501和HLA~DQB1^*0602基因分布频率显著高于哈萨克族正常人群(0.455:0.232,P〈0.001,OR=2.78;0.69比0.554,P=0.006,OR=1.80);HLA~DQB1^*0602基因阳性率在中低分化鳞癌组中(68.8%)的分布高于高分化鳞癌组(31.2%),差异有统计学意义(P〈0.05)。结论:HPV16E6的感染可能是新疆哈萨克族食管癌发生的重要因素之一。HLA—DRB1^*1501和HLA—DQB1^*0602是哈萨克族食管鳞癌的易感基因,其中HLA—DQB1^*0602与哈萨克族食管鳞癌的分化程度有关。 Objective: To explore the association between HPV16E6 infection, the polymorphisms of HLA-DRB1, DQB1 alleles and Kazakh esophageal squamous cell carcinomas in Xinjiang to further provide clues for Kazakh esophageal squamous cell carcinoma susceptibility genes. Methods: The HPV16E6 gene infection was detected by polymerase chain reaction (PCR) in 200 Kazakh patients with esophageal squamous cell carcinoma and 150 healthy controls . The polymorphisms of HLA-DRB1DRB1^*1501 and HLA-DQB1^*0602 were typed by sequence specific primer by using polymerase chain reaction (PCR-SSP) in 200 Kazakh patients with esophageal squamous cell carcinoma and 150 healthy controls. Results: Of the patients of Kazakhstan with esophageal squamous cell carcinoma, HPV16 E6 infection rate was 41%, significantly higher than that of ethnic Kazakh population whose infection rate was within the normal range of 14% (P〈 0.001, OR=3.94); no correlation between the normal controls with Kazakhstan HPV16 E6 infection rate and HLA-DRB1^* 1501, DQB1^*0602 was found (P〉0.05). Allele frequencies of HLA-DRB1^*1501 and HLA-DQB1^*0602 of the patients from Kazakhstan with esophageal squamous cell carcinoma was higher than those in healthy controls (0.455 vs. 0.232, P〈 0.001, OR=2.78; 0.69 vs. 0.554, P=-0.006, OR=1.80, respectively). HLA-DQB1^*0602 gene-positive allele in poorly differentiated squamous cell carcinoma group (68.8 percent) was higher than that of well-differentiated squamous cell carcinoma group (31.2%), the difference was statistically significant (P〈0.05). Conclusion: HPV16 E6 infection may be an important factor causing squamous cell carcinoma in the Xinjiang Kazakhstan population. Individuals carrying HLA-DRB1^*1501 and/or DQB1^*0602 may be more susceptible to esophageal squamous cell carcinoma. HLA-DQB1^*0602 is related to the differentiation of esophageal squamous cell carcinoma in the Kazakhstani participants.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第15期857-861,共5页 Chinese Journal of Clinical Oncology
基金 国家重点基础研究发展计划(973计划)基金(编号:2007CB516804) 国家科技支撑计划基金资助(编号:2009BA182B03)~~
关键词 HLA 食管鳞癌 遗传易感性 PCR—SSP HLA Esophageal squamous cell carcinoma Genetic susceptibility PCR-SSP
  • 相关文献

参考文献19

  • 1侯浚,陈志峰,贺宇彤.食管癌的流行病学[J].河北职工医学院学报,2000,17(4):27-29. 被引量:39
  • 2Duensing S,Duensing A Grum CP,et al.Human papillomavirus type 16E7 oncoprotein-induced abnormal centrosome sythesis is an early event in the evolving malignant phenotype[J].Gancer Res,2001,61(6):2356-2860.
  • 3Gillison ML,Koch WM,Capone RB,et al.Evidence for a causal association between human papillomavirus and a subset of hcad and neck cancers[J].J Nad Cancer Inst,2000,92(9):709-720.
  • 4范丽安,周光炎.人类基因组MHC测序及其免疫学意义[J].上海免疫学杂志,1999,19(6):321-322. 被引量:30
  • 5Chan PK,Cheung JL,Gheung TH,et al.HLA-DQB1 polymorphisms and risk for cervical c.ancer:A caSe-control study in a southem Chinese population[J].Gynecol Oncol,2007,105(3):736-741.
  • 6El-Chennawi FA,Auf FA,Metwally SS,et al.HLA-dass Ⅱ alleles in Egyptian patients with hepatocenular carcinoma[J].Immunol Invest,2008,37(7):661-674.
  • 7Bustin SA,Li SR,Phillips S,et al.Expression of HLA class Ⅱ in colorectal cancer:evidence for enhanced immunogenicity of microsatellite instability-positive tumours[J].Turnout Biol,2001,22(5):294-298.
  • 8Hamilton SR,Aaltonen LA.WHO classification of tumours of the digestive system[M].Lyon:IARC Press,2000.9-11.
  • 9Olerup O,Aldener A,Fogdell A.HLA-DQB1 and-DQA1 typing by PGR amplification with sequence-specific primers(PCR-SSP) in 2 hours[J].Tissue Antigens,1993,41(3):119-134.
  • 10Olerup O,Zetterquist H.HLA-DR typing by PCR amplification with sequence-specific primers(PCR-SSP)In 2 hours:An akematire to serological DR typing in clinical practice induding donor-recipient matching in cadaveric transplamation[J].Tissue Antigens,1992,39(5):225-235.

二级参考文献28

  • 1杨文献.食管癌的流行病学特征.杜百廉主编,食管癌,北京:中国科学技术出版社,1994,34~35.
  • 2山西省肿瘤防治办公室.山西省四十二个县(市)三年(1969—1971)食管、贲门癌死亡情况的调查报告[J].肿瘤防治研究,1973,4:20-36.
  • 3刘齐.食管癌.见卫生部肿瘤防治研究办公室主编.中国恶性肿瘤死亡调查研究所.北京:人民卫生出版社,1979.73-103.
  • 4中国医学科学院肿瘤研究所.我国食管癌流行因素的初步调查研究[J].肿瘤防治研究,1977,2:1-8.
  • 5卫生部肿瘤防治研究办公室.食管癌死亡率.见卫生部肿瘤防治研究办公室主编.中国恶性肿瘤死亡率资料汇编,1980.65—97.
  • 6卫生部帅瘤防治研究办公室.中国食管癌分布图.见中华人民共和国恶性肿瘤地图集编辑委员会主编.上海:中华地图学出版社,1979.31—38.
  • 7梁浩材.常见消化道癌的移民流行病学[J].肿瘤防治研究,1979,5:48-50.
  • 8Parking D M. Estimates of the world wide frequecy of sixteen majors Cancer in 1980. Int J Cancer, 1988,41 :184.
  • 9Waterhouse J. muir c. Correa P, at al. Cancer incidence in five continentes. In: "International Agency For Research on Cancer" Vol Ⅲ. Lyon: IARC Scientific Publications,1976.492 - 495.
  • 10王忠生 斯哈克.新疆新源县1974—1983年食首癌死亡动态[J].中华肿瘤杂志,1985,7:41-41.

共引文献72

同被引文献23

  • 1齐宗利,霍霞,张宝,杨海伟,丘波,彭琳,沈忠英,徐锡金.食管癌EC109细胞属人类乳头状瘤病毒18型阳性细胞株[J].汕头大学医学院学报,2006,19(3):136-138. 被引量:7
  • 2Zhao S, Yang X, Lu N, et al. The amount of surface HLA-Ion T lymphocytes decreases in breast infiltrating ductalcarcinoma patients[J]. J Int Med Res, 2011,39(2): 508-513.
  • 3Elliott RL, Jiang XP, Phillips JT, et al. Human leukocyteantigen G expression in breast cancer: role in immunosuppression[J]. Cancer Biother Radiopharm, 2011,26(2) : 153-157.
  • 4Karkada M,Weir GM, Quinton T,et al. A novelbreast/ovarian cancer peptide vaccine platform that promotesspecific type-1 but not Treg/Trl-type responses[J]. JImmunother, 2010,33(3): 250-261.
  • 5Seliger B, Ritz U, Ferrone S. Molecular mechanisms of HLAclass I antigen abnormalities following viral infection andtransformation[J]. Int J Cancer, 2006, 118: 129-138.
  • 6Tse KP, Su WH, Chang KP, et al. Genome-wide associationstudy reveals multiple nasopharyngeal carcinoma-associated lociwithin the HLA region at chromosome 6p21.3[J]. Am J HumGenet, 2009,85(2); 194-203.
  • 7Kubler K, Amdt PF, Wardelmann E, et al. HLA-class IIhaplotype associations with ovarian cancer[J]. Int J Cancer,2006,119(12): 2980-2985.
  • 8Kubler K, Amdt PF, Wardelmann E,et al. Geneticalterations of HLA-class II in ovarian cancer[J]. Int JCancer, 2008, 123(6): 1350-1356.
  • 9Chaudhuri S, Cariappa A, Tang M, et al. Genetic susceptibilityto breast cancer: HLA DQB* 03032 and HLA DRB1* 11 mayrepresent protective alleles[J]. Proc Natl Acad Sci USA, 2000,97(21): 11451-11454.
  • 10Gun FD, Oztruk OG,Polat A. HLA class-II allele frequenciesin Turkish breast cancer patients[J]. Med Oncol,2012,29(2): 466-471.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部